Jinyu Bio-technology Co., Ltd. (SHA:600201)

Jinyu Bio-technology Ratios and Metrics

Market cap in millions CNY. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	May 22, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	7,853	7,663	11,711	9,846	18,287	23,527
Market Cap Growth	-15.33%	-34.56%	18.94%	-46.16%	-22.27%	11.59%
Enterprise Value	6,927	6,475	10,150	8,877	16,727	21,846
Last Close Price	7.03	6.86	10.64	8.85	15.85	20.12
PE Ratio	96.72	70.31	41.29	46.74	47.84	57.92
Forward PE	38.09	21.05	31.48	23.75	22.33	38.03
PS Ratio	6.24	6.10	7.33	6.44	10.30	14.87
PB Ratio	1.45	1.42	2.07	1.84	3.29	4.47
P/TBV Ratio	1.67	1.62	2.34	2.10	3.82	5.22
P/FCF Ratio	38.76	38.34	82.67	63.71	114.01	49.92
P/OCF Ratio	29.08	26.47	28.23	28.57	34.30	33.63
PEG Ratio	0.83	0.84	0.84	0.84	0.84	0.84
EV/Sales Ratio	5.50	5.16	6.35	5.81	9.42	13.81
EV/EBITDA Ratio	34.87	26.26	23.22	19.69	28.59	37.62
EV/EBIT Ratio	-	174.08	40.81	35.23	42.43	53.68
EV/FCF Ratio	34.19	32.39	71.64	57.44	104.28	46.35
Debt / Equity Ratio	0.00	0.00	0.00	0.00	0	-
Debt / EBITDA Ratio	0.09	0.07	0.01	0.02	0.00	-
Debt / FCF Ratio	0.09	0.09	0.03	0.07	0.01	-
Asset Turnover	0.19	0.18	0.24	0.24	0.28	0.27
Inventory Turnover	2.12	1.94	2.04	2.14	2.06	2.09
Quick Ratio	2.64	2.58	3.17	3.53	3.34	4.15
Current Ratio	3.11	3.02	3.59	4.07	4.01	4.69
Return on Equity (ROE)	1.34%	1.88%	5.04%	3.67%	7.19%	8.34%
Return on Assets (ROA)	-0.16%	0.34%	2.34%	2.42%	3.82%	4.29%
Return on Capital (ROIC)	-0.20%	0.42%	2.82%	2.88%	4.55%	5.00%
Return on Capital Employed (ROCE)	-	0.60%	4.10%	4.40%	6.70%	7.30%
Earnings Yield	1.02%	1.42%	2.42%	2.14%	2.09%	1.73%
FCF Yield	2.58%	2.61%	1.21%	1.57%	0.88%	2.00%
Dividend Yield	0.42%	0.44%	0.75%	0.68%	0.69%	0.60%
Payout Ratio	111.98%	82.00%	23.55%	59.04%	35.11%	16.52%
Buyback Yield / Dilution	-1.01%	0.10%	1.61%	1.39%	0.35%	-2.09%
Total Shareholder Return	-0.59%	0.53%	2.36%	2.07%	1.04%	-1.49%

Updated Oct 30, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.